Previous 10 | Next 10 |
Thousands of canine and feline specimens tested surfaced no positive results to date WESTBROOK, Maine , March 13, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that the company has seen ...
In this episode of Industry Focus: Wildcard , Motley Fool analysts Jason Moser and Brian Feroldi take a closer look at a new IPO in the healthcare space that aims to fix all the pain points plaguing today's primary healthcare model. We find out about its business strategy and how it aims to a...
Tech and life science names make up a bulk of the investment focus in a fund now available to retail investors from Franklin Resources (NYSE: BEN ). On Monday (February 24), the investment firm Franklin Templeton unveiled the Franklin Focused Growth Fund, managed by Matthew Moberg, senior ...
Insider buying decreased significantly last week with insiders purchasing $39.19 million of stock compared to $100.09 million in the week prior. Selling increased with insiders selling $1.83 billion of stock last week compared to $1.22 billion in the week prior. Sell/Buy Ratio: The insider...
WESTBROOK, Maine , Feb. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced that the Company's Board of Directors has authorized the repurchase of an additional 5.0 million shares of the Company's common stock under its ongoing share repurchase pro...
Image source: The Motley Fool. IDEXX Laboratories Inc (NASDAQ: IDXX) Q4 2019 Earnings Call Jan 31, 2020 , 8:30 a.m. ET Operator Continue reading
IDEXX Laboratories, Inc. (IDXX) Q4 2019 Earnings Conference Call January 31, 2020, 08:30 ET Company Participants Brian McKeon - CFO, EVP & Treasurer Jonathan Mazelsky - President, CEO & Director Conference Call Participants Nathan Rich - Goldman Sachs Group Ryan Dan...
Idexx Laboratories (NASDAQ: IDXX) delivered a sizzling 40% gain in 2019, handily beating the overall market. The animal healthcare company's companion animal business especially performed well. But Idexx's strong momentum faced a test when the company provided its fiscal 2019 fourth-qu...
IDEXX Laboratories ( IDXX ) Q4 results: Revenues: $605.4M (+10.2%); CAG: $529.8M (+10.6%). More news on: IDEXX Laboratories, Inc., Healthcare stocks news, Earnings news and commentary, , Read more ...
IDEXX Laboratories (NASDAQ: IDXX ): Q4 GAAP EPS of $1.04 beats by $0.14 . More news on: IDEXX Laboratories, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories Inc. Website:
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am ET on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements. Individuals can access a live ...
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals PR Newswire WESTBROOK, Maine , July 30, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published i...
2024-07-19 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...